Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Bayer
AstraZeneca
Washington University School of Medicine
Indiana University
GlaxoSmithKline
M.D. Anderson Cancer Center
Indiana University
Memorial Sloan Kettering Cancer Center
IDRx Inc. - A GSK Company
M.D. Anderson Cancer Center
British Columbia Cancer Agency
Turning Point Therapeutics, Inc.
Tempus AI
UNC Lineberger Comprehensive Cancer Center